FDA approves controversial new drug designed to slow the progress of ALS
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.
https://www.nbcnews.com/health/health-news/fda-approves-controversial-new-drug-designed-slow-progression-als-rcna48763